Illumina Inc. (ILMN): Price and Financial Metrics

Illumina Inc. (ILMN): $139.83

1.15 (-0.82%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add ILMN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#32 of 360

in industry

ILMN Price/Volume Stats

Current price $139.83 52-week high $238.55
Prev. close $140.98 52-week low $89.00
Day low $139.78 Volume 1,226,200
Day high $146.08 Avg. volume 1,871,688
50-day MA $139.21 Dividend yield N/A
200-day MA $152.24 Market Cap 22.22B

ILMN Stock Price Chart Interactive Chart >

ILMN POWR Grades

  • Quality is the dimension where ILMN ranks best; there it ranks ahead of 77.78% of US stocks.
  • ILMN's strongest trending metric is Quality; it's been moving up over the last 26 weeks.
  • ILMN ranks lowest in Momentum; there it ranks in the 27th percentile.

ILMN Stock Summary

  • ILMN has a higher market value than 89.55% of US stocks; more precisely, its current market capitalization is $20,697,992,000.
  • Price to trailing twelve month operating cash flow for ILMN is currently 51.62, higher than 93.38% of US stocks with positive operating cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, ILLUMINA INC is reporting a growth rate of -74.09%; that's higher than merely 18% of US stocks.
  • If you're looking for stocks that are quantitatively similar to ILLUMINA INC, a group of peers worth examining would be CYCN, MRCY, QLGN, SMSI, and BHIL.
  • Visit ILMN's SEC page to see the company's official filings. To visit the company's web site, go to www.illumina.com.

ILMN Valuation Summary

  • ILMN's price/earnings ratio is -19.7; this is 167.58% lower than that of the median Healthcare stock.
  • Over the past 243 months, ILMN's price/earnings ratio has gone down 11.2.

Below are key valuation metrics over time for ILMN.

Stock Date P/S P/B P/E EV/EBIT
ILMN 2023-12-29 5.0 3.7 -19.7 -22.3
ILMN 2023-12-28 5.1 3.8 -20.1 -22.7
ILMN 2023-12-27 5.1 3.8 -20.1 -22.8
ILMN 2023-12-26 5.0 3.8 -19.9 -22.5
ILMN 2023-12-22 5.0 3.8 -19.8 -22.4
ILMN 2023-12-21 5.0 3.8 -19.8 -22.4

ILMN Growth Metrics

    Its year over year net cashflow from operations growth rate is now at -59.76%.
  • Its 4 year revenue growth rate is now at 46.66%.
  • The year over year cash and equivalents growth rate now stands at -69.52%.
Over the past 52 months, ILMN's revenue has gone up $1,342,000,000.

The table below shows ILMN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 4,584 392 -4,404
2022-09-30 4,699 527 -4,153
2022-06-30 4,692 307 -20
2022-03-31 4,656 435 700
2021-12-31 4,526 545 762
2021-09-30 4,280 669 906

ILMN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ILMN has a Quality Grade of B, ranking ahead of 94.64% of graded US stocks.
  • ILMN's asset turnover comes in at 0.489 -- ranking 48th of 75 Measuring and Control Equipment stocks.
  • AMOT, AATC, and TRMB are the stocks whose asset turnover ratios are most correlated with ILMN.

The table below shows ILMN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-04 0.489 0.686 0.187
2021-04-04 0.448 0.676 0.175
2021-01-03 0.439 0.680 0.173
2020-09-27 0.443 0.690 0.165
2020-06-28 0.464 0.703 0.174
2020-03-29 0.497 0.704 0.209

ILMN Price Target

For more insight on analysts targets of ILMN, see our ILMN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $459.00 Average Broker Recommendation 1.92 (Hold)

Illumina Inc. (ILMN) Company Bio


Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencinggenotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California. (Source:Wikipedia)


ILMN Latest News Stream


Event/Time News Detail
Loading, please wait...

ILMN Latest Social Stream


Loading social stream, please wait...

View Full ILMN Social Stream

Latest ILMN News From Around the Web

Below are the latest news stories about ILLUMINA INC that investors may wish to consider to help them evaluate ILMN as an investment opportunity.

Here's Why You Should Retain Illumina (ILMN) Stock for Now

Investors are optimistic about Illumina's (ILMN) strength in the genomics market and strong solvency position.

Yahoo | December 28, 2023

Small Caps Are On A Tear Including Speculative Biotechs

So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation.

TalkMarkets.com | December 26, 2023

Nucleus Genomics Wants To Make Personalized Health Care a Reality

NORTHAMPTON, MA / ACCESSWIRE / December 21, 2023 / Illumina A New York-based startup is on a mission to bring the power of whole-genome sequencing to the world Originally published on Illumina News Center Nucleus Genomics is realizing the dream set ...

Yahoo | December 21, 2023

Heard on the Street: Illumina Nears the End of Its Painful Grail Saga

Grail’s screening test, called Galleri, could one day help save countless lives by catching cancer in the bloodstream early. After losing in court [against the Federal Trade Commission](https://www.wsj.com/health/healthcare/court-sides-with-ftc-finding-illumina-grail-deal-anticompetitive-ad2efe8d), the company has finally [thrown in the towel](https://www.wsj.com/health/healthcare/illumina-to-divest-itself-of-cancer-test-maker-grail-3f74f1e8) on keeping Grail. The maker of gene-sequencing machines said Sunday it will pursue the divestiture of Grail through a third-party sale or capital markets transaction, with a goal of completing terms by the middle of 2024.

Yahoo | December 19, 2023

S&P 500 Gains and Losses Today: Enphase's Cost Cutting Charges Up Solar Stocks

The S&P 500 gained 0.6% on Tuesday, Dec. 19, 2023, amid optimism on Fed rate cuts, strong housing data, and the traditional "Santa Claus rally."

Yahoo | December 19, 2023

Read More 'ILMN' Stories Here

ILMN Price Returns

1-mo -2.22%
3-mo 27.36%
6-mo -17.00%
1-year -32.29%
3-year -68.29%
5-year -56.46%
YTD 0.42%
2023 -31.14%
2022 -46.85%
2021 2.82%
2020 11.53%
2019 10.61%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!